Executive Summary
An extraordinary cluster of 43 US companies filed 8-Ks on January 28, 2026, all disclosing executive and director changes under Item 5.02, spanning diverse sectors including financials (5 firms), biotech/pharma (5), transportation (3), insurance (3), and software (2), signaling potential systemic governance event, AGM fallout, or disclosure backlog rather than isolated issues. All filings show uniformly neutral sentiment with average materiality of 4.4/10 and 16/43 (37%) rated medium risk, but zero enriched quantitative data across period-over-period trends, insider trading activity, forward-looking guidance, capital allocation details, or financial ratios—highlighting extreme opacity that amplifies uncertainty. No YoY/QoQ deteriorations or improvements disclosed, no insider buys/sells or pledges noted, and no M&A/transaction ties, suggesting changes lack immediate financial materiality but warrant scrutiny for hidden instability. Portfolio-level pattern: Elevated governance risk in small/mid-cap names (most filings), with co-occurring Items like 7.01 Reg FD (11 cases) and 5.07 shareholder votes (4 cases) implying possible succession planning or board refreshes amid neutral metrics. Implications: Investors face near-term volatility until follow-up details emerge; relative underperformance likely for medium-risk names vs. peers with transparent changes. No sector-specific growth/margin trends identifiable due to data gaps, but financials show 100% low-medium risk cluster.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from January 26, 2026.
Investment Signals(12)
- RPC INC↓(BULLISH)▲
Low risk officer change with Item 8.01 other events, no disclosed negative metrics or insider selling, potential routine succession
- MARINE PRODUCTS CORP↓(BULLISH)▲
Materiality 3/10 low impact change, neutral sentiment, no financial deterioration or governance red flags beyond opacity
- ALT5 Sigma Corp↓(BULLISH)▲
Standard Item 5.02 filing with exhibits, low risk, absence of medium risk flags suggests non-disruptive appointment
- AiXin Life International, Inc.↓(BULLISH)▲
226 KB filing size indicates detailed exhibits, low materiality 3/10, no performance declines noted
Low risk bank change, 167 KB exhibits, no quantitative insider activity or capital allocation shifts
- US BANCORP↓(BULLISH)▲
Major bank with low risk Item 5.02, materiality 3/10, no forward-looking downgrades or ratio declines disclosed
- ▲
Low risk environmental services change, no operational metric declines or insider concerns
- JABIL INC↓(BULLISH)▲
Electronics mfg low risk change, no margin compression or YoY revenue drops in associated data
- KB HOME↓(BULLISH)▲
Homebuilder low risk officer event, absence of debt-to-equity worsening or buyback suspensions
- V F CORP↓(BULLISH)▲
Apparel giant low risk filing, no disclosed ROE declines or dividend cuts
- KOHLS Corp↓(BULLISH)▲
Retail low materiality 3/10, neutral with no sales volume drops or cost trends
- Limoneira CO↓(BULLISH)▲
Agri low risk, no capacity/volume metrics negatively impacted
Risk Flags(10)
- Pacira BioSciences, Inc./Governance↓[HIGH RISK]▼
Medium risk pharma officer change + Item 7.01, lack of position/reason details may signal undisclosed instability
- El Pollo Loco Holdings, Inc./Leadership↓[HIGH RISK]▼
Medium risk 206 KB filing, critical successor details missing, potential impact on operations
Medium risk bank with Item 2.02 results undisclosed, unknown if tied to performance issues
- ▼
Medium risk + Item 5.03 bylaws change, undisclosed amendments heighten control risks
- Workiva INC/Software↓[HIGH RISK]▼
Medium-high materiality 6/10 + Item 7.01, no change reasons disclosed amid potential growth concerns
- Ocean Power Technologies, Inc./Board↓[HIGH RISK]▼
Medium risk materiality 6/10 + Item 5.07 vote, unknown outcomes may indicate contested changes
- ARCBEST CORP /DE//Transport↓[HIGH RISK]▼
Medium risk trucking change + Item 7.01, opacity in timing/reasons flags execution risks
- SenesTech, Inc./Biotech↓[HIGH RISK]▼
Medium risk pest control firm, repeated 8-K/A filing suggests evolving instability
- Sonoma Pharmaceuticals, Inc./Pharma↓[HIGH RISK]▼
Medium risk 287 KB exhibits, unknown key position affected signals uncertainty
- TON Strategy Co/Strategic↓[HIGH RISK]▼
Medium-high materiality 6/10 + Item 7.01, no appointment/resignation status heightens concern
Opportunities(8)
- ◆
Explicit potential for improved governance if appointments add expertise, bylaws update could enhance structure
- Ocean Power Technologies, Inc./Board Strengthening↓(OPPORTUNITY)◆
Item 5.07 vote + change suggests planned refresh, materiality 6/10 for alpha in renewables
- Pasithea Therapeutics Corp./Governance Pivot↓(OPPORTUNITY)◆
Item 5.07 vote + 5.03 bylaws + change offers board refresh potential in biotech turnaround
- Progressive CORP/OH//Insurance Succession↓(OPPORTUNITY)◆
Item 2.02 results + low risk change, 624 KB filing may reveal strong metrics supporting stability
- Schneider National, Inc./Transport↓(OPPORTUNITY)◆
Item 7.01 Reg FD with change, potential positive disclosure on leadership continuity in trucking
- COLONY BANKCORP INC/Bank Earnings↓(OPPORTUNITY)◆
Item 2.02 + 7.01 + change, opportunity if results offset opacity in regional bank
- LOUISIANA-PACIFIC CORP/Building↓(OPPORTUNITY)◆
Large 653 KB filing + Item 7.01, exhibits may uncover undervalued succession in materials
- Accenture plc/Consulting↓(OPPORTUNITY)◆
Item 5.07 vote + change, potential expertise addition in high-growth sector
Sector Themes(6)
- Financials Turnover Wave◆
5 banks (US Bancorp, First Commonwealth, Valley National, Burke & Herbert, Colony) filed changes same day, 80% low risk but avg materiality 4/10; implies sector-wide routine elections vs crisis, watch for deposit/loan trends
- Biotech/Pharma Opacity Cluster◆
5 firms (Pacira, Sonoma, SenesTech x2, Pasithea) all medium risk avg, no metrics but repeated filings signal leadership flux amid R&D pressures; relative underperformance risk vs stable peers
- Transportation Leadership Shifts◆
3 trucking firms (Schneider, ArcBest) + marine, all Item 7.01 heavy (67%), neutral but potential for capacity/volume catalysts if appointments operational experts
- Insurance Governance Updates◆
3 carriers (Progressive, Assurant, AiXin?) low risk cluster, no ROE/margin declines noted; capital allocation stability likely, dividend continuity opportunity
- Software & Funds Bylaws Ties◆
4 filings (Workiva/Liveperson software, Highland funds) with medium risk + governance items (5.03/5.07), avg materiality 5/10; pattern of structural refreshes for growth/scalability
- Broad Retail/Industrials Dispersion◆
7 diverse (El Pollo, VF, Kohls, KB Home, Jabil, etc.) low materiality avg 4/10, no cross trends in sales/costs but cluster flags consumer cyclical risks
Watch List(8)
High materiality 6/10 medium risk + Item 7.01, monitor Q1 2026 call for change details/guidance impact
Item 5.07 outcomes + change, watch Feb 2026 for board refresh confirmation
Materiality 6/10 + Item 7.01, track follow-up on officer role/reason by Feb 4, 2026
Medium risk + Item 7.01, monitor for FDA/partner updates tied to leadership
Dual 8-K/8-K/A medium risk, watch for restated details or insider filings next week
Item 5.03 changes undisclosed, monitor fund NAV/performance post-governance shift
Item 5.07 + multiple items, track biotech catalysts Q1 2026
Medium risk + Item 7.01, watch freight metrics in next 10-Q for change context
Filing Analyses(43)
28-01-2026
Zeo ScientifiX, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's identity, position, reason for change, timing, or compensatory arrangements are disclosed.
28-01-2026
The company filed an 8-K on January 28, 2026 (AccNo: 0001140361-26-002589, Size: 254 KB) under Item 5.02 disclosing an officer change event. No specific details on the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or succession context are provided in the filing excerpt. No quantitative metrics, financial impacts, or governance implications are mentioned.
- ·Event date: January 28, 2026
- ·Filing size: 254 KB
- ·AccNo: 0001140361-26-002589
28-01-2026
RPC Inc filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007185), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any financial metrics are disclosed. Filing size: 167 KB; sector NOT_DISCLOSED.
28-01-2026
Marine Products Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.
28-01-2026
Ultra Clean Holdings, Inc. filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided in the filing summary.
28-01-2026
ALT5 Sigma Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, or any quantitative metrics provided.
28-01-2026
Pacira BioSciences, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including officer names, positions affected, appointment or resignation status, reasons, and any financial metrics are NOT_DISCLOSED.
28-01-2026
AiXin Life International, Inc. filed an 8-K on 2026-01-28 (AccNo: 0001493152-26-003883, Size: 226 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative data are disclosed.
- ·Sector: sector not specified
28-01-2026
Burke & Herbert Financial Services Corp. filed an 8-K on January 28, 2026 (AccNo: 0001964333-26-000008), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, or any quantitative financial metrics are disclosed.
- ·Filing size: 167 KB
28-01-2026
US Bancorp (DE) filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or impacts were disclosed.
28-01-2026
El Pollo Loco Holdings, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed in the provided filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
- ·AccNo: 0001104659-26-007246
- ·Filing size: 206 KB
- ·Event date: January 28, 2026
- ·Sector: sector not specified
28-01-2026
FIRST COMMONWEALTH FINANCIAL CORP /PA/ filed an 8-K on 2026-01-28 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data, scheduled events, or forward-looking statements are mentioned.
28-01-2026
Perma-Fix Environmental Services Inc. filed an 8-K on January 28, 2026 (AccNo: 0001493152-26-003909), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals affected, nature of changes, reasons, or effective dates are disclosed in the filing summary.
28-01-2026
LOUISIANA-PACIFIC CORP filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details such as the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, or any quantitative financial metrics are provided. Filing size is 653 KB with no performance data, positive or negative metrics, or period-over-period comparisons mentioned.
28-01-2026
The company filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-026858) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as officer names, titles, reasons for the change, appointment vs. resignation status, effective dates, or board composition impacts are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
Highland Opportunities & Income Fund filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits; no specific names, reasons, financial impacts, or quantitative details are provided.
28-01-2026
Highland Global Allocation Fund filed an 8-K on January 28, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also reports under Item 5.03 amendments to articles of incorporation or bylaws, or a change in fiscal year, and under Item 9.01 includes financial statements and exhibits. No specific names, reasons for changes, quantitative impacts, or other details are disclosed.
28-01-2026
Progressive Corp/OH/ filed an 8-K on January 28, 2026 (AccNo: 0000080661-26-000071, Size: 624 KB), disclosing results of operations and financial condition under Item 2.02, an officer change, departure, election, appointment, or compensatory arrangements under Item 5.02, and financial statements/exhibits under Item 9.01. Specific details on the officer position, name, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, scheduled events, or governance implications are provided in the filing summary.
28-01-2026
Schneider National, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the affected officer, position, reason for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.
28-01-2026
Workiva Inc filed an 8-K on 2026-01-28 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed in the provided information. No positive or negative performance metrics are mentioned.
28-01-2026
Ocean Power Technologies, Inc. filed an 8-K on 2026-01-28 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on affected positions, names, reasons for changes, vote outcomes, or any quantitative metrics are disclosed.
28-01-2026
ARCBEST CORP /DE/ filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.
28-01-2026
The company filed an 8-K on 2026-01-28 (AccNo: 0001091667-26-000011) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer involved, position affected, reason for change, effective date, or any quantitative impacts are provided.
28-01-2026
SenesTech, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003828), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for the change (e.g., retirement, performance), timing, or any quantitative financial terms are provided in the filing summary. No positive or negative metrics, performance comparisons, or governance impacts are mentioned.
- ·Filing size: 142 KB
- ·Sector: not specified
28-01-2026
Valley National Bancorp filed a Form 8-K on 2026-01-28 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, timing, or any quantitative metrics are provided. This is a standard governance disclosure without additional context on implications.
28-01-2026
Sonoma Pharmaceuticals, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001683168-26-000589, Size: 287 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
28-01-2026
Jabil Inc filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the affected position, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
KB Home filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
28-01-2026
TON Strategy Co filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
Pasithea Therapeutics Corp. filed an 8-K on January 28, 2026, disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 5.07 submission of matters to a vote of security holders. No specific details on affected positions, individuals involved, reasons for changes, voting outcomes, amendment contents, or any quantitative metrics are disclosed.
28-01-2026
V F CORP filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.
28-01-2026
Accenture plc filed an 8-K on 2026-01-28 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.07 covers submission of matters to a vote of security holders, while Item 9.01 references financial statements and exhibits. No specific details on personnel changes, voting results, or quantitative metrics are provided in the filing summary.
28-01-2026
Kohl's Corp filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names, reasons for change, effective dates, or any quantitative metrics are disclosed.
28-01-2026
Limoneira CO filed an 8-K on January 28, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, reasons, timing, or any quantitative metrics are disclosed.
28-01-2026
LIVEPERSON INC filed an 8-K on 2026-01-28 disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected positions, names, reasons for changes, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics, financial data, or further context on the leadership change implications are disclosed.
28-01-2026
COLONY BANKCORP INC filed an 8-K on 2026-01-28 (AccNo: 0000711669-26-000004) reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the leadership change—including position affected, name, appointment/resignation status, reason, or timing—are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are disclosed in the provided filing information.
28-01-2026
Lifeward Ltd. filed an 8-K on 2026-01-28 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and submission of matters to a vote of security holders under Item 5.07. Specific details including key position affected, appointment or resignation status, reasons for change, names, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, period-over-period comparisons, or scheduled events are mentioned.
28-01-2026
Zoned Properties, Inc. filed an 8-K on January 28, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as affected positions, names, reasons for change, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
28-01-2026
FTAI Aviation Ltd. filed an 8-K on 2026-01-28 (AccNo: 0001140361-26-002691, Size: 215 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics are mentioned.
28-01-2026
SenesTech, Inc. filed an 8-K on 2026-01-28 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are disclosed in the provided filing summary. No quantitative financial metrics, performance comparisons, or other material data are mentioned.
28-01-2026
Assurant, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or financial impacts are disclosed.
28-01-2026
DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are provided.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 43 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings